Watson rolls out anti epileptic drug
Watson’s Levetiracetam Extended-Release 500mg and 750mg tablets are generic equivalent to Keppra XR of UCB. Keppra is an anti-epileptic drug which is indicated for the treatment of partial
Amgen has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for Repatha (evolocumab) supporting its broader use prior to a first heart attack or stroke.